Literature DB >> 7511701

Myelination in cerebellar slice cultures: development of a system amenable to biochemical analysis.

L M Notterpek1, P N Bullock, S Malek-Hedayat, R Fisher, L H Rome.   

Abstract

Myelin deposition and maintenance are critical to proper function of the mammalian nervous system. Previous investigations of myelination in the central nervous system (CNS) were hampered by the lack of an in vitro system that can faithfully reproduce in vivo events yet is amenable to biochemical investigation. We have developed a procedure, based on organotypic cultures, which permits efficient preparation of large numbers of cerebellar slice cultures that can be easily manipulated. Cultures have been examined to document myelination biochemically (by incorporation of [35S]sulfate into sulfolipids), immunohistochemically (by labeling the myelin components myelin basic protein and galactocerebroside), and morphologically (by both light and electron microscopy). We tested the effects of biologically active peptides and antibodies on myelination in the thin slices. The results indicate that the cultures provide an in vitro system that can be used to examine specific cellular events that occur during CNS myelination.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7511701     DOI: 10.1002/jnr.490360603

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

1.  Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors.

Authors:  M Lee; V Lelievre; P Zhao; M Torres; W Rodriguez; J Y Byun; S Doshi; Y Ioffe; G Gupta; A E de los Monteros; J de Vellis; J Waschek
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Purkinje cell survival and axonal regeneration are age dependent: an in vitro study.

Authors:  I Dusart; M S Airaksinen; C Sotelo
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

3.  The developmental loss of the ability of Purkinje cells to regenerate their axons occurs in the absence of myelin: an in vitro model to prevent myelination.

Authors:  Lamia Bouslama-Oueghlani; Rosine Wehrlé; Constantino Sotelo; Isabelle Dusart
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

Review 4.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

5.  A phenotypic culture system for the molecular analysis of CNS myelination in the spinal cord.

Authors:  Hedvika Davis; Mercedes Gonzalez; Maria Stancescu; Rachal Love; James J Hickman; Stephen Lambert
Journal:  Biomaterials       Date:  2014-07-23       Impact factor: 12.479

6.  The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulation.

Authors:  Aiden Haghikia; Ralf Gold
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

7.  Characterisation of transverse slice culture preparations of postnatal rat spinal cord: preservation of defined neuronal populations.

Authors:  Stavros I Stavridis; Faramarz Dehghani; Horst-Werner Korf; Nils P Hailer
Journal:  Histochem Cell Biol       Date:  2005-05-12       Impact factor: 4.304

8.  Myelinated, synapsing cultures of murine spinal cord--validation as an in vitro model of the central nervous system.

Authors:  C E Thomson; M McCulloch; A Sorenson; S C Barnett; B V Seed; I R Griffiths; M McLaughlin
Journal:  Eur J Neurosci       Date:  2008-09-10       Impact factor: 3.386

9.  Simvastatin induces cell death in a mouse cerebellar slice culture (CSC) model of developmental myelination.

Authors:  Zhongmin Xiang; Steven A Reeves
Journal:  Exp Neurol       Date:  2008-09-27       Impact factor: 5.330

10.  Zebrafish myelination: a transparent model for remyelination?

Authors:  Clare E Buckley; Paul Goldsmith; Robin J M Franklin
Journal:  Dis Model Mech       Date:  2008 Nov-Dec       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.